These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 29774104)

  • 21. Predictive value of quantitative diffusion-weighted imaging and 18-F-FDG-PET in head and neck squamous cell carcinoma treated by (chemo)radiotherapy.
    Martens RM; Noij DP; Koopman T; Zwezerijnen B; Heymans M; de Jong MC; Hoekstra OS; Vergeer MR; de Bree R; Leemans CR; de Graaf P; Boellaard R; Castelijns JA
    Eur J Radiol; 2019 Apr; 113():39-50. PubMed ID: 30927958
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imaging of tumour hypoxia and metabolism in patients with head and neck squamous cell carcinoma.
    Zegers CM; van Elmpt W; Hoebers FJ; Troost EG; Öllers MC; Mottaghy FM; Lambin P
    Acta Oncol; 2015; 54(9):1378-84. PubMed ID: 26213313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overlap of highly FDG-avid and FMISO hypoxic tumor subvolumes in patients with head and neck cancer.
    Mönnich D; Thorwarth D; Leibfarth S; Pfannenberg C; Reischl G; Mauz PS; Nikolaou K; la Fougère C; Zips D; Welz S
    Acta Oncol; 2017 Nov; 56(11):1577-1582. PubMed ID: 28849721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interim 4'-[methyl-
    Mitamura K; Norikane T; Yamamoto Y; Fujimoto K; Takami Y; Hoshikawa H; Toyohara J; Nishiyama Y
    EJNMMI Res; 2021 Feb; 11(1):13. PubMed ID: 33566186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Local recurrence of squamous cell carcinoma of the head and neck after radio(chemo)therapy: Diagnostic performance of FDG-PET/MRI with diffusion-weighted sequences.
    Becker M; Varoquaux AD; Combescure C; Rager O; Pusztaszeri M; Burkhardt K; Delattre BMA; Dulguerov P; Dulguerov N; Katirtzidou E; Caparrotti F; Ratib O; Zaidi H; Becker CD
    Eur Radiol; 2018 Feb; 28(2):651-663. PubMed ID: 28812148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FDG-PET delayed imaging for the detection of head and neck cancer recurrence after radio-chemotherapy: comparison with MRI/CT.
    Kubota K; Yokoyama J; Yamaguchi K; Ono S; Qureshy A; Itoh M; Fukuda H
    Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):590-5. PubMed ID: 14722678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting Treatment Resistance in Head and Neck Squamous Cell Carcinoma - Proof of Concept for CT Radiomics-Based Identification of Resistant Sub-Volumes.
    Bogowicz M; Pavic M; Riesterer O; Finazzi T; Garcia Schüler H; Holz-Sapra E; Rudofsky L; Basler L; Spaniol M; Ambrusch A; Hüllner M; Guckenberger M; Tanadini-Lang S
    Front Oncol; 2021; 11():664304. PubMed ID: 34123824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic performance of
    Chaput A; Robin P; Podeur F; Ollivier M; Keromnes N; Tissot V; Nonent M; Salaün PY; Rousset J; Abgral R
    Laryngoscope; 2018 Feb; 128(2):378-385. PubMed ID: 28600822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical utility of 18F-FDG PET/CT in assessing the neck after concurrent chemoradiotherapy for Locoregional advanced head and neck cancer.
    Ong SC; Schöder H; Lee NY; Patel SG; Carlson D; Fury M; Pfister DG; Shah JP; Larson SM; Kraus DH
    J Nucl Med; 2008 Apr; 49(4):532-40. PubMed ID: 18344440
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 18F-FDG versus 11C-choline PET/CT for the imaging of advanced head and neck cancer after combined intra-arterial chemotherapy and radiotherapy: the time period during which PET/CT can reliably detect non-recurrence.
    Ito K; Yokoyama J; Kubota K; Morooka M; Shiibashi M; Matsuda H
    Eur J Nucl Med Mol Imaging; 2010 Jul; 37(7):1318-27. PubMed ID: 20306040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of rigid and non-rigid image registration on test-retest variability of quantitative [18F]FDG PET/CT studies.
    van Velden FH; van Beers P; Nuyts J; Velasquez LM; Hayes W; Lammertsma AA; Boellaard R; Loeckx D
    EJNMMI Res; 2012 Mar; 2(1):10. PubMed ID: 22404895
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined PET/CT-perfusion in patients with head and neck cancers might predict failure after radio-chemotherapy: a proof of concept study.
    Pietsch C; de Galiza Barbosa F; Hüllner MW; Schmid DT; Haerle SK; Huber GF; Studer G; Hany TF; Veit-Haibach P
    BMC Med Imaging; 2015 Dec; 15():60. PubMed ID: 26714448
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FDG-PET/CT as prognostic factor and surveillance tool for postoperative radiation recurrence in locally advanced head and neck cancer.
    Kim G; Kim YS; Han EJ; Yoo IeR; Song JH; Lee SN; Lee JH; Choi BO; Jang HS; Yoon SC
    Radiat Oncol J; 2011 Dec; 29(4):243-51. PubMed ID: 22984677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma.
    Cacicedo J; Fernandez I; Del Hoyo O; Navarro A; Gomez-Iturriaga A; Pijoan JI; Martinez-Indart L; Escudero J; Gomez-Suarez J; de Zarate RO; Perez JF; Bilbao P; Rades D
    Clin Transl Oncol; 2017 Nov; 19(11):1337-1349. PubMed ID: 28540535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of preoperative 18F-FDG PET/CT for primary head and neck squamous cell carcinoma.
    Joo YH; Yoo IeR; Cho KJ; Park JO; Nam IC; Kim CS; Kim MS
    Eur Arch Otorhinolaryngol; 2014 Jun; 271(6):1685-91. PubMed ID: 23949547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of 11-C-methionine positron emission tomography for the delineation of the tumor volume in pharyngo-laryngeal squamous cell carcinoma: comparison with FDG-PET and CT.
    Geets X; Daisne JF; Gregoire V; Hamoir M; Lonneux M
    Radiother Oncol; 2004 Jun; 71(3):267-73. PubMed ID: 15172141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Response evaluation of cervical lymph nodes after chemoradiation in patients with head and neck cancer - does additional [18F]FDG-PET-CT help?
    Dejaco D; Uprimny C; Widmann G; Riedl D; Moser P; Arnold C; Steinbichler TB; Kofler B; Schartinger VH; Virgolini I; Riechelmann H
    Cancer Imaging; 2020 Sep; 20(1):69. PubMed ID: 32993805
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictive value of suvmax changes between two sequential post-therapeutic FDG-pet in head and neck squamous cell carcinomas.
    Stadler TM; Hüllner MW; Broglie MA; Morand GB
    Sci Rep; 2020 Oct; 10(1):16689. PubMed ID: 33028940
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical utility of
    Ha SC; Roh JL; Kim JS; Lee JH; Choi SH; Nam SY; Kim SY
    Acta Otolaryngol; 2019 Sep; 139(9):810-815. PubMed ID: 31274365
    [No Abstract]   [Full Text] [Related]  

  • 40. [18F]-FDG PET-CT prediction of response to induction chemotherapy in head and neck squamous cell carcinoma: preliminary findings.
    Gavid M; Prevot-Bitot N; Timoschenko A; Gallet P; Martin C; Prades JM
    Eur Ann Otorhinolaryngol Head Neck Dis; 2015 Feb; 132(1):3-7. PubMed ID: 25439623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.